Markus Wartmann

cPLA2 is phosphorylated and activated by MAP kinase

Lih‐Ling Lin, Markus Wartmann, Alice Lin et al. · Cell · 1993 · 1.9K citations

Signal Transduction, Molecular Physiology, Map Kinase +6

Discovery of 3-(2,6-Dichloro-3,5-dimethoxy-phenyl)-1-{6-[4-(4-ethyl-piperazin-1-yl)-phenylamino]-pyrimidin-4-yl}-1-methyl-urea (NVP-BGJ398), A Potent and Selective Inhibitor of the Fibroblast Growth Factor Receptor Family of Receptor Tyrosine Kinase

Vito Guagnano, Pascal Furet, Carsten Spanka et al. · Journal of Medicinal Chemistry · 2011 · 484 citations · Full text

Pharmaceutical Chemistry, Tumor Biology, Medicinal Chemistry +19

CDK 4/6 Inhibitors Sensitize PIK3CA Mutant Breast Cancer to PI3K Inhibitors

Sadhna Vora, Dejan Juric, Nayoon Kim et al. · Cancer Cell · 2014 · 428 citations · Full text

Pi3k Inhibitors, Breast Oncology, Medicine +10

Control of MAP kinase activation by the mitogen-induced threonine/tyrosine phosphatase PAC1

Yvona Ward, Shashi Kumar Gupta, Peter N. Jensen et al. · Nature · 1994 · 331 citations

Signal Transduction, Cell Regulation, Biochemistry +12

AEE788

Peter Traxler, Peter R. Allegrini, Ralf Brandt et al. · Cancer Research · 2004 · 317 citations

Angiogenesis, Family Members, Medicine +10